已收盤 11-20 16:00:00 美东时间
-0.190
-0.26%
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler cut the price target for General Mills Inc (NYSE:GIS) from $41 to $35. Piper Sandler analyst Mic...
11-12 20:07
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # Alcon Inc. 2026财年第三季度业绩回顾摘要 ## 1. 财务业绩 **整体营收表现:** - 第三季度净销售额达27亿美元,同比增长5%(按固定汇率计算增长6%) - 前九个月营收同比增长6% **分部业绩:** - **手术板块(Surgical):** 营收15亿美元,同比增长4% - 植入物(Implantables):营收4.22亿美元,同比下降2%(其中IOL人工晶体下降1%,主要受美国高端IOL市场竞争压力影响) - 手术耗材(Consumables):营收7.89亿美元,同比增长6%(受手术量提升及价格上涨驱动)
11-12 12:56
BTIG analyst Ryan Zimmerman reiterates Alcon (NYSE:ALC) with a Buy and maintains $74 price target.
11-12 01:14
Alcon shares are trading lower after the company reported mixed Q3 financial results and narrowed its FY26 sales guidance below estimates.
11-11 21:35
CoreWeave劲升14.30%;NEBIUS劲升11.43%;Coherent大升8.54%
11-11 17:11